CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Fundação Antonio Prudente (FAP). A C Camargo Cancer Center (Institutional affiliation from the last research proposal) Birthplace: Brazil
Bachelor's degree in Biological Sciences from the Federal University of Santa Catarina (2002) and a Master's degree in Neurosciences (2005) from the same institution. Earned a Ph.D. through the Graduate Program in Sciences with an emphasis on Oncology at the Antônio Prudente Foundation (2009). Completed postdoctoral training at the Ludwig Institute for Cancer Research and the International Research Center (CIPE) at A.C. Camargo Cancer Center/Antônio Prudente Foundation. Currently serves as a Researcher III at A.C. Camargo Cancer Center and a faculty member of the Antônio Prudente Foundation's Graduate Program. Co-founder and researcher at Aljava Biotech. (Source: Lattes Curriculum)
| Articles published in Pesquisa para Inovação FAPESP about the researcher: |
| Choice of best medication for cancer treatment can be facilitated by predictive testing |
| More itemsLess items |
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
This document describes an investment proposal to use the Institutional Technical Funding (RTI) granted by FAPESP in 2024 to AC Camargo Cancer Center. The International Research Center (CIPE) of AC Camargo Cancer Center provides core facilities and technical services to all researchers to carry out cutting-edge basic and translational research in Oncology. This year, the institution propo…
This document describes an investment proposal to use the Institutional Technical Funding (RTI) granted by FAPESP in 2022 to AC Camargo Cancer Center. The International Research Center (CIPE) of AC Camargo Cancer Center provides core facilities and technical services to all researchers to carry out cutting-edge basic and translational research in Oncology. This year, the institution propo…
This document describes an investment proposal to use the Institutional Technical Funding (RTI) granted by FAPESP in 2021 to AC Camargo Cancer Center. The International Research Center (CIPE) of AC Camargo Cancer Center provides core facilities and technical services to all researchers to carry out cutting-edge basic and translational research in Oncology. This year, the institution propo…
Soft tissue sarcomas (STS) are rare neoplasms with different morphological patterns of mesenchymal cells that can evolve with high rates of morbidity and mortality. High-grade tumors larger than 10 cm and deep have a worse prognosis due their high metastatic capacity (mainly to the lungs), with median survival not exceeding 15%. The low efficacy in the treatment of these tumors is in part…
(Only some records are available in English at this moment)
With the advent of the immune checkpoint blockade (ICB), immunotherapy has revolutionised the way how cancer patients have been treated over the last years. Groundbreaking advances have been achieved upon cancer patient treatment with anti-PD-1 and anti-CTLA-4. However, globally, only 30-50% of cancer patients respond partially or completely to anti-PD-1 and/or anti-CTLA-4. In clear cell …
| 1 / 1 | Ongoing grants |
| 6 / 6 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 2 / 0 | Completed scholarships in Brazil |
| 10 / 8 | All research grants and scholarships |
| Associated processes | |